Atlanta pharmaceutical company Inhibikase plans $18 million IPO

Inhibikase Therapeutics was launched in 2008 as an entrepreneurial start-up in Atlanta with initial financial support from the Georgia Research Alliance.

Inhibikase Therapeutics was launched in 2008 as an entrepreneurial start-up in Atlanta with initial financial support from the Georgia Research Alliance.

View Original Article Source